Okinawa University has announced that intraperitoneal chemotherapy for advanced ovarian cancer is now covered by insurance. This development offers patients a new treatment option. The university's research highlights the effectiveness of this approach in managing cancerous peritonitis. The treatment involves delivering chemotherapy directly into the abdominal cavity. This method is believed to enhance drug concentration at the site of the tumor. The insurance coverage change comes after extensive clinical trials and regulatory review. Patients diagnosed with advanced stages of ovarian cancer may now access this treatment more easily. The university emphasizes the importance of early detection and personalized treatment plans. This decision reflects ongoing efforts to improve cancer care in Japan. The treatment is expected to benefit a significant number of patients in the coming months.